Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06036446 · ClinicalTrials.gov registry record · NA
LATe Cerclage in High-risk Pregnancies (LATCH)
A NA study of Premature Birth, sponsored by Thomas Jefferson University.
- Recruiting
- Registry status
- NA
- Development phase
- 329
- Enrollment target
- 1
- Study location
NCT06036446: Recruiting NA study of Premature Birth, sponsored by Thomas Jefferson University.
NCT06036446 is a NA study of Premature Birth that is actively recruiting participants, run by Thomas Jefferson University. The registered enrollment target is 329 participants, below the 386-participant average among 38 other Premature Birth trials with a reported enrollment target (15% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06036446, a NA study of Premature Birth, is actively recruiting participants, sponsored by Thomas Jefferson University.
- RECRUITING
- Registry status
- NA
- Development phase
- 329 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to determine whether cervical cerclage reduces the risk of preterm birth in patients with a short transvaginal ultrasound (TVU) cervical length (CL) ≤25mm between 24 0/7-26 6/7 weeks.
Conditions Studied
Interventions
- PROCEDURE Cervical cerclage
- DRUG Vaginal Suppository Progesterone
Study Locations (1)
Pennsylvania
- Thomas Jefferson University - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 329 participants |
| Start Date | 2023-11-10 |
| Est. Completion | 2029-02 |
| Phase | NA |
What NCT06036446 shows while recruiting
NCT06036446 is an interventional study that assigns participants to a tested intervention. The registered 329 participants enrollment target is mid-sized for trials with a published cap, below the 386-participant average among 38 other Premature Birth trials with a reported enrollment target (15% lower).
The record links to 1 condition, with Premature Birth appearing as the primary indexed condition, and to 2 interventions - of which Cervical cerclage is the first listed.
NCT06036446 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06036446 about?
NCT06036446 is a clinical study titled "LATe Cerclage in High-risk Pregnancies (LATCH)". The goal of this clinical trial is to determine whether cervical cerclage reduces the risk of preterm birth in patients with a short transvaginal ultrasound (TVU) cervical length (CL) ≤25mm between 24 0/7-26 6/7 weeks.
What is the current status of trial NCT06036446?
This trial is currently recruiting. It is a NA study. The enrollment target is 329 participants. The study started on 2023-11-10. Estimated completion is 2029-02.
What conditions does trial NCT06036446 study?
This clinical trial studies the following conditions: Premature Birth.
What interventions are being tested in trial NCT06036446?
The interventions under investigation include: Cervical cerclage (PROCEDURE), Vaginal Suppository Progesterone (DRUG).
Who is sponsoring clinical trial NCT06036446?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06036446 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Premature Birth
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06036446's enrollment target sits among peer trials
329 8th of 38 higher than 31 of 38 other Premature Birth trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Premature Birth trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Randomized Controlled Trial of Impact of Wearable, Wireless Breast Pumps on Frequency and Efficacy of Milk Expression in Mothers of Premature Infants
RECRUITING · NA
-
Optimizing Family Counseling for Anticipated Extremely Preterm Delivery
RECRUITING · NA
-
The Periviable GOALS Decision Support Tool
RECRUITING · NA
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
-
Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants
RECRUITING · NA
-
Healing Tiny Minds: Rural Recovery Through Virtual and Lived Experience Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00359684 · 330 participants
Use of Cysteamine in the Treatment of Cystinosis
- NCT03817502 · 330 participants · Phase 3
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
- NCT03922724 · 330 participants · Phase 2
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
- NCT03932773 · 330 participants · NA
Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI